在接受MIS-C评估的儿科患者中,规范性实验室值范围
Thomas Graf1, Nathan M Money2, Sindhoosha Malay1
1Department of Pediatrics, Division of Pediatric Hospital Medicine, Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland, Ohio, USA.
Emergency medicine international
|December 4, 2025
概括
诊断儿童多系统炎症综合征 (MIS-C) 是很困难的. 这项研究发现MIS-C与其他疾病之间的实验室值存在显著差异,有助于医生区分诊断并减少不必要的测试.
科学领域:
- 儿童传染病 儿童传染病
- 临床免疫学 临床免疫学
- 流行病学 流行病学
背景情况:
- 诊断儿童多系统炎症综合征 (MIS-C) 存在挑战,因为其症状与其他儿科疾病重叠.
- 确定规范性实验室值对于准确的MIS-C诊断至关重要.
研究的目的:
- 为了确定MIS-C患者的规范性实验室值.
- 为了比较MIS-C患者和那些被评估为MIS-C但被诊断患有其他疾病的患者之间的实验室值.
主要方法:
- 一项多中心研究审查了6个月至18岁的1319名患者的病历,这些患者被评估为MIS-C.
- 人口统计,临床表现和实验室值在MIS-C和非MIS-C组之间进行了比较.
- 所有患者的最终诊断和相关的实验室值都被记录在案.
主要成果:
- 在1319名患者中,293人 (22.2%) 被诊断为MIS-C.
- 与非MIS-C患者相比,MIS-C患者在D-二聚合物,费里丁,纤维素原,素和大脑尿素水平上表现出显著差异.
- 常见的非MIS-C诊断包括病毒性疾病,急性COVID-19,肌炎和川崎病.
结论:
- 在大流行期间,许多被评估为MIS-C的患者接受了替代诊断.
- 这些发现可以帮助儿科医生区分MIS-C和其他发烧性疾病.
- 这些数据可能有助于减少对怀疑MIS-C.的不必要实验室检测.
相关概念视频
Serum Studies: Renal Function Tests
341
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
341
Pharmacokinetics in Pediatric Patients: Drug Metabolism
176
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
176
Pharmacokinetics in Pediatric Patients: Drug Excretion
195
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
195
Pharmacokinetics in Pediatric Patients: Drug Distribution
244
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
244
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
231
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
231


